Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT07021547
PHASE1

A Study of LY3867070 in Healthy Participants

Sponsor: Eli Lilly and Company

View on ClinicalTrials.gov

Summary

The purpose of this study is to evaluate how well LY3867070 is tolerated and what side effects may occur in healthy participants. The study drug will be administered orally. Blood tests will be performed to investigate how the body processes the study drug and how the study drug affects the body.

Official title: A Single- and Multiple-Ascending Dose Study to Evaluate the Safety and Pharmacokinetics of LY3867070 in Healthy Participants

Key Details

Gender

All

Age Range

18 Years - 65 Years

Study Type

INTERVENTIONAL

Enrollment

196

Start Date

2025-05-27

Completion Date

2026-08

Last Updated

2026-01-21

Healthy Volunteers

Yes

Conditions

Interventions

DRUG

LY3867070

Administered orally

DRUG

Placebo

Administered orally

Locations (2)

Anaheim Clinical Trials, LLC

Anaheim, California, United States

Fortrea Clinical Research Unit

Dallas, Texas, United States